கேந்ய ஹோண்டா News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from கேந்ய ஹோண்டா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In கேந்ய ஹோண்டா Today - Breaking & Trending Today
'Timely, interesting and important': Study links gut microbe metabolism to longevity foodnavigator-usa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foodnavigator-usa.com Daily Mail and Mail on Sunday newspapers.
Middle-aged spread dramatically raises the risk of digestive system cancers, researchers have warned. The threat of a tumour developing in the stomach or liver soars 13 per cent for every extra unit of body mass index (BMI), according to a study. And the likelihood of gullet and pancreatic cancer also increases by 10 and 6 per cent respectively. Obesity is a major factor in all four types of the disease – and shedding the pounds can help prevent them, scientists said. The study, carried out by British and Swedish researchers, analysed more than 350,000 people from the UK Biobank database. They found that being tall was associated with a greater risk of all cancers investigated. ....
People who live to 100 have unique gut bacteria signatures livescience.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from livescience.com Daily Mail and Mail on Sunday newspapers.
The Microbiome Gains Momentum in Cancer Immunotherapy The Microbiome Gains Momentum in Cancer Immunotherapy Vedanta Biosciences develops drugs made from defined bacterial consortia. One of these drugs, a cancer drug called VE800, addresses a challenge that may commonly occur with microbiome-engaging cancer immunotherapeutics. The problem is variability in microbiome signatures. Vedanta’s CEO, Bernat Olle, PhD, says that with cancer, there is no “night and day type of signature” like that seen with Clostridium difficile infections. Olle suggests that overcoming this problem will require big data sets, big sample sizes, and multiomic analyses. The Microbiome Gains Momentum in Cancer Immunotherapy ....